Norges Bank Royalty Pharma PLC Transaction History

Norges Bank

$716 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $126 Million - $144 Million	4,809,343 New	4,809,343 $127 Million
Q4 2023 Feb 09, 2024	BUY	$26.21 - $29.22 $112 Million - $125 Million	4,262,736 New	4,262,736 $120 Million
Q3 2023 Nov 13, 2024	BUY	$26.26 - $31.38 $109 Million - $130 Million	4,136,337 New	4,136,337 $112 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $91.8 Million - $110 Million	-3,497,604 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$29.6 - $36.56 $21.1 Million - $26 Million	-712,192 Reduced 14.81%	4,097,151 $126 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $100 Million - $124 Million	-3,393,497 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$32.77 - $39.4 $143 Million - $172 Million	4,367,708 New	4,367,708 $157 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $149 Million - $168 Million	3,816,357 New	3,816,357 $151 Million
Q3 2022 Nov 13, 2023	BUY	$39.88 - $44.65 $139 Million - $156 Million	3,497,604 New	3,497,604 $141 Million
Q2 2022 Aug 14, 2023	BUY	$37.53 - $44.22 $127 Million - $150 Million	3,393,497 New	3,393,497 $143 Million
Q1 2022 May 12, 2023	SELL	$37.46 - $42.44 $27.9 Million - $31.6 Million	-744,961 Reduced 19.52%	3,071,396 $120 Million
Q1 2022 May 09, 2022	SELL	$37.46 - $42.44 $111 Million - $126 Million	-2,960,240 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$35.17 - $42.48 $104 Million - $126 Million	2,960,240 New	2,960,240 $118 Million
Q3 2021 Nov 14, 2022	BUY	$36.14 - $42.24 $103 Million - $121 Million	2,860,730 New	2,860,730 $103 Million
Q3 2021 Nov 05, 2021	SELL	$36.14 - $42.24 $101 Million - $118 Million	-2,794,952 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$39.85 - $46.63 $111 Million - $130 Million	2,794,952 New	2,794,952 $115 Million
Q2 2021 Aug 10, 2021	SELL	$39.85 - $46.63 $110 Million - $129 Million	-2,763,137 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$42.34 - $52.82 $117 Million - $146 Million	2,763,137 New	2,763,137 $121 Million
Q1 2021 May 07, 2021	SELL	$42.34 - $52.82 $43.3 Million - $54 Million	-1,022,571 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$36.12 - $50.05 $36.9 Million - $51.2 Million	1,022,571 New	1,022,571 $51.2 Million
Q4 2020 Feb 10, 2021	SELL	$36.12 - $50.05 $26.1 Million - $36.2 Million	-722,363 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$38.56 - $48.36 $27.9 Million - $34.9 Million	722,363 New	722,363 $30.4 Million
Q3 2020 Nov 10, 2020	SELL	$38.56 - $48.36 $88.8 Million - $111 Million	-2,302,508 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$44.5 - $52.11 $102 Million - $120 Million	2,302,508 New	2,302,508 $112 Million

Others Institutions Holding RPRX

# of Institutions

412

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account